1.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: Other
Protocol IDs: LAL-RI/96, NCT00494897
|
|
2.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9410, POG-SIMAL-8
|
|
3.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9802, E-R9802, NCCTG-R9802, SWOG-R9802, RTOG-DEV-1012, NCT00003375, RTOG-98-02
|
|
4.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-75100
|
|
5.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 18
Sponsor:
Protocol IDs: SJCRH-ALL-TT-8
|
|
6.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7841
|
|
7.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: WCCC-CO-7711R, NCI-D80-048-183
|
|
8.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-4480
|
|
9.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 20 and under
Sponsor:
Protocol IDs: CHOP-204
|
|
10.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 25 to 65
Sponsor:
Protocol IDs: DFCI-75116
|
|
11.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-192P
|
|
12.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 60
Sponsor:
Protocol IDs: EORTC-LAM-4
|
|
13.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 20 and over
Sponsor:
Protocol IDs: SAFR-CT-MM-2
|
|
14.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BGSM-62384, NCI-T87-0147D, T87-0147
|
|
15.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: DFCI-77001, NCI-T83-1310D, T83-1310
|
|
16.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1285
|
|
17.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-81001, NCI-D82-018-0400, D82-018-0400
|
|
18.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-86-C-92A, NCI-NMOB-855, NCI-T86-0137N, T86-0137
|
|
19.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1586
|
|
20.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1277R
|
|
21.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 20
Sponsor: NCI
Protocol IDs: POG-8698
|
|
22.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: SJCRH-RMS-V, NCI-T86-0152D, T86-0152
|
|
23.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 20
Sponsor:
Protocol IDs: ARG-GATLA-3LMA83
|
|
24.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1588
|
|
25.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8862
|
